-
Je něco špatně v tomto záznamu ?
Serum and Mucosal CD30 in Pediatric Inflammatory Bowel Diseases: Useful Biomarker for Diagnosis and Disease Activity Monitoring
O. Fabian, A. Klocperk, T. Lerchova, P. Jencova, L. Stolova, M. Belhajova, D. Voriskova, D. Kazeka, A. Vicha, O. Hradsky, J. Bronsky
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
ProQuest Central
od 1997-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2009-07-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest)
od 1997-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-01-01 do Před 1 rokem
Family Health Database (ProQuest)
od 1997-01-01 do Před 1 rokem
- MeSH
- biologické markery analýza MeSH
- Crohnova nemoc * diagnóza MeSH
- dítě MeSH
- idiopatické střevní záněty * komplikace MeSH
- inhibitory TNF MeSH
- lidé MeSH
- střevní sliznice patologie MeSH
- T-lymfocyty - podskupiny MeSH
- ulcerózní kolitida * diagnóza MeSH
- zánět patologie MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: Inflammatory bowel diseases (IBD) frequently manifest in pediatric age, but may have atypical clinical, histological and laboratory features. Their underlying immune pathophysiology is incompletely understood, rendering quick diagnosis followed by tailored therapy difficult. The tumor necrosis factor superfamily receptor CD30 has been proposed as a potential marker of ulcerative colitis (UC) and has also been associated with elevated Th2 helper T cells. METHODS: A cohort of pediatric patients with UC and Crohn's disease (CD) was evaluated for serum soluble CD30 (sCD30) using ELISA and expression of CD30 and subpopulations of Th1/Th2/Th17 lymphocytes in the gastrointestinal mucosa using flow cytometry (FCM). The dataset is supported by endoscopic and microscopic activity of the disease and basic laboratory markers of inflammation. RESULTS: The cohort consisted of 102 observations from 94 patients. sCD30 levels did not differ between patients with CD or UC. However, sCD30 levels correlated with levels of CRP, ESR, fecal calprotectin and albumin and also with clinical activity of the disease in patients with both UC and CD. FCM was not helpful in evaluation of mucosal CD30, which was lowly expressed and not associated with the diagnosis or disease activity. We show augmented Th2 and Th1/17 response in terminal ileum and right-sided colon and decreased Th1/17 response in left-sided colon of UC patients. T lymphocyte subsets were also affected by anti-TNF treatment and patients' age. CONCLUSIONS: Neither sCD30 nor mucosal CD30 expression was helpful in differentiating between UC and CD. sCD30 seems to reflect a degree of systemic inflammation and clinical activity in IBD.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23004448
- 003
- CZ-PrNML
- 005
- 20230425141414.0
- 007
- ta
- 008
- 230418s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s10620-022-07677-4 $2 doi
- 035 __
- $a (PubMed)36056999
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Fabian, Ondrej $u Clinical and Transplant Pathology Centre, Institute for Clinical and Experimental Medicine, Videnska 1958/9, Prague 4, 140 21, Czech Republic. ondrej.fabian@ikem.cz $u Department of Pathology and Molecular Medicine, 3Rd Faculty of Medicine, Charles University and Thomayer Hospital, Videnska 800, Prague 4, 140 59, Czech Republic. ondrej.fabian@ikem.cz $u Department of Pathology and Molecular Medicine, 2nd Faculty of Medicine, Charles University and University Hospital Motol, V Uvalu 84, Prague 5, 150 06, Czech Republic. ondrej.fabian@ikem.cz $1 https://orcid.org/0000000203932415
- 245 10
- $a Serum and Mucosal CD30 in Pediatric Inflammatory Bowel Diseases: Useful Biomarker for Diagnosis and Disease Activity Monitoring / $c O. Fabian, A. Klocperk, T. Lerchova, P. Jencova, L. Stolova, M. Belhajova, D. Voriskova, D. Kazeka, A. Vicha, O. Hradsky, J. Bronsky
- 520 9_
- $a BACKGROUND: Inflammatory bowel diseases (IBD) frequently manifest in pediatric age, but may have atypical clinical, histological and laboratory features. Their underlying immune pathophysiology is incompletely understood, rendering quick diagnosis followed by tailored therapy difficult. The tumor necrosis factor superfamily receptor CD30 has been proposed as a potential marker of ulcerative colitis (UC) and has also been associated with elevated Th2 helper T cells. METHODS: A cohort of pediatric patients with UC and Crohn's disease (CD) was evaluated for serum soluble CD30 (sCD30) using ELISA and expression of CD30 and subpopulations of Th1/Th2/Th17 lymphocytes in the gastrointestinal mucosa using flow cytometry (FCM). The dataset is supported by endoscopic and microscopic activity of the disease and basic laboratory markers of inflammation. RESULTS: The cohort consisted of 102 observations from 94 patients. sCD30 levels did not differ between patients with CD or UC. However, sCD30 levels correlated with levels of CRP, ESR, fecal calprotectin and albumin and also with clinical activity of the disease in patients with both UC and CD. FCM was not helpful in evaluation of mucosal CD30, which was lowly expressed and not associated with the diagnosis or disease activity. We show augmented Th2 and Th1/17 response in terminal ileum and right-sided colon and decreased Th1/17 response in left-sided colon of UC patients. T lymphocyte subsets were also affected by anti-TNF treatment and patients' age. CONCLUSIONS: Neither sCD30 nor mucosal CD30 expression was helpful in differentiating between UC and CD. sCD30 seems to reflect a degree of systemic inflammation and clinical activity in IBD.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a inhibitory TNF $7 D000079424
- 650 12
- $a idiopatické střevní záněty $x komplikace $7 D015212
- 650 12
- $a ulcerózní kolitida $x diagnóza $7 D003093
- 650 12
- $a Crohnova nemoc $x diagnóza $7 D003424
- 650 _2
- $a biologické markery $x analýza $7 D015415
- 650 _2
- $a T-lymfocyty - podskupiny $7 D016176
- 650 _2
- $a střevní sliznice $x patologie $7 D007413
- 650 _2
- $a zánět $x patologie $7 D007249
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Klocperk, Adam $u Department of Immunology, 2Nd Faculty of Medicine, Charles University and University Hospital Motol, V Uvalu 84, Prague 5, 150 06, Czech Republic
- 700 1_
- $a Lerchova, Tereza $u Gastroenterology and Nutrition Unit, Department of Paediatrics, 2Nd Faculty of Medicine, Charles University and University Hospital Motol, V Uvalu 84, Prague 5, 150 06, Czech Republic
- 700 1_
- $a Jencova, Pavla $u Department of Paediatric Haematology and Oncology, 2Nd Faculty of Medicine, Charles University and University Hospital Motol, V Uvalu 84, Prague 5, 150 06, Czech Republic
- 700 1_
- $a Stolova, Lucie $u Department of Paediatric Haematology and Oncology, 2Nd Faculty of Medicine, Charles University and University Hospital Motol, V Uvalu 84, Prague 5, 150 06, Czech Republic
- 700 1_
- $a Belhajova, Marie $u Department of Paediatric Haematology and Oncology, 2Nd Faculty of Medicine, Charles University and University Hospital Motol, V Uvalu 84, Prague 5, 150 06, Czech Republic
- 700 1_
- $a Voriskova, Dagmar $u Department of Paediatric Haematology and Oncology, 2Nd Faculty of Medicine, Charles University and University Hospital Motol, V Uvalu 84, Prague 5, 150 06, Czech Republic
- 700 1_
- $a Kazeka, Denis $u Gastroenterology and Nutrition Unit, Department of Paediatrics, 2Nd Faculty of Medicine, Charles University and University Hospital Motol, V Uvalu 84, Prague 5, 150 06, Czech Republic
- 700 1_
- $a Vicha, Ales $u Department of Paediatric Haematology and Oncology, 2Nd Faculty of Medicine, Charles University and University Hospital Motol, V Uvalu 84, Prague 5, 150 06, Czech Republic
- 700 1_
- $a Hradsky, Ondrej $u Gastroenterology and Nutrition Unit, Department of Paediatrics, 2Nd Faculty of Medicine, Charles University and University Hospital Motol, V Uvalu 84, Prague 5, 150 06, Czech Republic
- 700 1_
- $a Bronsky, Jiri $u Gastroenterology and Nutrition Unit, Department of Paediatrics, 2Nd Faculty of Medicine, Charles University and University Hospital Motol, V Uvalu 84, Prague 5, 150 06, Czech Republic
- 773 0_
- $w MED00009570 $t Digestive diseases and sciences $x 1573-2568 $g Roč. 68, č. 2 (2023), s. 460-470
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36056999 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230418 $b ABA008
- 991 __
- $a 20230425141411 $b ABA008
- 999 __
- $a ok $b bmc $g 1924877 $s 1190657
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 68 $c 2 $d 460-470 $e 20220903 $i 1573-2568 $m Digestive diseases and sciences $n Dig Dis Sci $x MED00009570
- LZP __
- $a Pubmed-20230418
